Allied Healthcare Products, Inc. (AHPIQ)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Allied Healthcare Products, Inc. (AHPIQ) with AI Score 46/100 (Weak). Allied Healthcare Products, Inc. manufactures and markets respiratory products and medical gas equipment for the healthcare industry. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Allied Healthcare Products, Inc. (AHPIQ) Healthcare & Pipeline Overview
Allied Healthcare Products, Inc. provides respiratory and medical gas equipment to the healthcare industry, serving hospitals and alternate care facilities. The company's product range includes respiratory care, anesthesia, and emergency medical equipment. Currently under Chapter 11 liquidation, its future operations are uncertain amidst a competitive medical device market.
Investment Thesis
Allied Healthcare Products, Inc. faces significant challenges due to its Chapter 11 liquidation status, approved on January 19, 2024. The company's market capitalization is $0.00B, reflecting its distressed financial state. While the company historically served a diverse customer base with a range of respiratory and medical gas equipment, the liquidation process raises substantial concerns about asset recovery and potential returns for investors. The high beta of 7.24 indicates extreme volatility, typical for companies in financial distress. Investors should carefully consider the implications of the liquidation plan and the uncertainty surrounding the company's future.
Based on FMP financials and quantitative analysis
Key Highlights
- Chapter 11 Liquidation: Approved on January 19, 2024, indicating the company is ceasing operations and liquidating assets.
- Market Cap of $0.00B: Reflects the company's distressed financial condition and lack of investor confidence.
- Beta of 7.24: Indicates extremely high volatility, suggesting significant risk associated with the stock.
- Serves a broad customer base: Historically served hospitals, home healthcare providers, and emergency medical services, indicating a diverse market reach before financial distress.
- Product Range: Offered a wide array of respiratory and medical gas equipment, suggesting a comprehensive product portfolio prior to liquidation.
Competitors & Peers
Strengths
- Comprehensive product range in respiratory care and medical gas equipment.
- Established distribution network.
- Long-standing presence in the healthcare industry.
- Diverse customer base.
Weaknesses
- Chapter 11 liquidation status.
- Financial instability.
- Uncertain future operations.
- Potential loss of customer relationships.
Catalysts
- Ongoing: Potential for asset sales during the liquidation process.
- Ongoing: Court proceedings related to the Chapter 11 liquidation.
Risks
- Ongoing: Complete loss of investment due to liquidation.
- Potential: Delays in the liquidation process.
- Potential: Lawsuits or claims impacting asset distribution.
- Ongoing: Limited information and transparency due to OTC Other listing.
Growth Opportunities
- Expansion into Home Healthcare Market: The increasing demand for home respiratory care products presents a growth opportunity, provided the company can restructure and regain its footing. The home healthcare market is driven by an aging population and the desire for cost-effective care outside of hospitals. However, given the current liquidation status, this opportunity is unlikely to be realized.
- Development of Advanced Respiratory Devices: Investing in research and development to create advanced respiratory devices could drive future growth. The market for innovative respiratory solutions is expanding, with a focus on improved patient outcomes and ease of use. However, this requires significant capital investment, which is unlikely given the company's financial situation.
- Strategic Partnerships and Acquisitions: Forming strategic alliances or acquiring complementary businesses could broaden the company's product portfolio and market reach. Partnerships can provide access to new technologies and distribution channels. However, the Chapter 11 status makes such partnerships and acquisitions highly improbable.
- Geographic Expansion into Emerging Markets: Expanding into emerging markets, where healthcare infrastructure is developing, could offer significant growth potential. These markets often have unmet needs for respiratory care products and medical gas equipment. However, this requires substantial investment and logistical capabilities, which are currently constrained.
- Focus on Telehealth and Remote Monitoring: Integrating telehealth capabilities into respiratory devices could enhance patient care and monitoring. Remote monitoring allows for proactive management of respiratory conditions and reduces the need for hospital visits. However, this requires technological expertise and infrastructure, which may be beyond the company's current capabilities.
Opportunities
- Restructuring and emerging from bankruptcy (highly unlikely).
- Capitalizing on the growing demand for home healthcare products (unlikely).
- Developing innovative respiratory solutions (unlikely).
- Expanding into new geographic markets (unlikely).
Threats
- Intense competition from larger medical device companies.
- Regulatory changes impacting product approvals.
- Economic downturn affecting healthcare spending.
- Loss of key personnel during liquidation.
Competitive Advantages
- Established product portfolio in respiratory care.
- Distribution network serving hospitals and home healthcare providers.
- Brand recognition within the medical gas equipment market.
- Proprietary designs and technologies in certain product lines.
About AHPIQ
Allied Healthcare Products, Inc., incorporated in 1979 and headquartered in Chicago, Illinois, manufactures and markets a comprehensive range of respiratory products and medical gas equipment. These products are utilized across various healthcare settings, including hospitals and alternate care facilities, worldwide. The company's offerings span respiratory care/anesthesia products, such as air compressors, humidifiers, and equipment dryers, to respiratory disposable products, including oxygen tubing and ventilator circuits. Allied Healthcare Products also provides home respiratory care products, including oxygen cylinders and nebulizers. Furthermore, the company offers medical gas equipment, including in-wall medical system components, flowmeters, and pressure regulators, essential for delivering medical gases to patients. Its emergency medical products line includes resuscitation devices, trauma kits, and patient handling equipment. Allied Healthcare Products serves a diverse customer base, including hospitals, hospital equipment dealers, construction contractors, home healthcare providers, and emergency medical product dealers. However, on May 8, 2023, the company filed for Chapter 11 bankruptcy, and the plan was approved as Chapter 11 liquidation on January 19, 2024, casting uncertainty over its future operations.
What They Do
- Manufactures air compressors and calibration equipment for respiratory applications.
- Offers humidifiers, croup tents, and equipment dryers.
- Provides respiratory disposable products like oxygen tubing, facemasks, and cannulas.
- Supplies aluminum oxygen cylinders, oxygen regulators, and pneumatic nebulizers.
- Produces medical gas equipment, including in-wall medical system components and headwalls.
- Offers flowmeters, vacuum regulators, and pressure regulators for medical gas delivery.
- Provides emergency medical products, including resuscitation valves and portable resuscitation systems.
- Supplies trauma and patient handling products, such as spine immobilization products and trauma burn kits.
Business Model
- Manufacturing and selling respiratory care and medical gas equipment.
- Distribution through hospitals, hospital equipment dealers, and home healthcare providers.
- Sales of disposable respiratory products for recurring revenue.
- Providing equipment for emergency medical services.
Industry Context
Allied Healthcare Products, Inc. operated within the medical devices industry, a sector characterized by innovation, regulatory oversight, and intense competition. The industry is driven by factors such as an aging population, increasing prevalence of chronic respiratory diseases, and technological advancements in medical equipment. Companies like CRYO and GTHR compete in similar segments. However, Allied Healthcare's Chapter 11 liquidation distinguishes it from healthier competitors, placing it outside the normal competitive dynamics of the industry. The medical device market is projected to continue growing, but Allied Healthcare's ability to participate is severely limited by its current financial state.
Key Customers
- Hospitals and acute care facilities.
- Home healthcare providers.
- Hospital equipment dealers.
- Emergency medical services (EMS) providers.
Financials
Chart & Info
Allied Healthcare Products, Inc. (AHPIQ) stock price: Price data unavailable
Latest News
No recent news available for AHPIQ.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AHPIQ.
Price Targets
Wall Street price target analysis for AHPIQ.
MoonshotScore
What does this score mean?
The MoonshotScore rates AHPIQ's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Daniel C. Dunn
CEO
Daniel C. Dunn serves as the CEO of Allied Healthcare Products, Inc. Information regarding his detailed career history and educational background is not available in the provided data. As CEO, he manages 146 employees. His leadership is currently focused on navigating the company through its Chapter 11 liquidation process.
Track Record: Given the company's current Chapter 11 liquidation status, assessing Daniel C. Dunn's track record is challenging. The company's financial difficulties and subsequent bankruptcy filing overshadow any potential achievements during his tenure. The primary focus has been on managing the liquidation process.
AHPIQ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors and may be subject to less regulatory oversight than exchange-listed companies on NYSE or NASDAQ. This tier typically involves higher risks due to the potential for less transparency and greater price volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: Lack of comprehensive financial reporting increases investment risk.
- Low Liquidity: Difficulty in buying or selling shares due to low trading volume.
- Bankruptcy Risk: Ongoing liquidation process poses a significant risk to investors.
- Price Volatility: High volatility due to speculative trading and uncertainty.
- Regulatory Scrutiny: Potential for regulatory actions due to non-compliance.
- Verify the current status of the Chapter 11 liquidation plan.
- Assess the potential for any asset recovery for shareholders.
- Review available financial statements, if any, for historical performance.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor regarding the suitability of this investment.
- Check for any regulatory filings or announcements related to the liquidation.
- Evaluate the management team's plan for the liquidation process.
- Historical operations as a manufacturer of respiratory products.
- Established customer base in the healthcare industry (prior to bankruptcy).
- Previous compliance with regulatory requirements (prior to bankruptcy).
What Investors Ask About Allied Healthcare Products, Inc. (AHPIQ)
What does Allied Healthcare Products, Inc. do?
Allied Healthcare Products, Inc. historically manufactured and marketed a range of respiratory products and medical gas equipment for the healthcare industry. Their products included air compressors, humidifiers, oxygen cylinders, flowmeters, and resuscitation devices. The company served hospitals, home healthcare providers, and emergency medical services. However, due to Chapter 11 liquidation, the company is ceasing operations and selling off its assets.
What do analysts say about AHPIQ stock?
Given Allied Healthcare Products, Inc.'s Chapter 11 liquidation status and OTC Other listing, formal analyst coverage is unlikely. The company's market capitalization is effectively zero, and its financial condition is distressed. Investment in AHPIQ is highly speculative and carries a significant risk of total loss due to the ongoing liquidation process. Investors should conduct thorough due diligence and consult with a financial advisor before considering any investment.
What are the main risks for AHPIQ?
The primary risk for AHPIQ is the ongoing Chapter 11 liquidation, which means the company is selling its assets to pay off creditors. Investors face a high probability of losing their entire investment. Additional risks include limited financial disclosure, low liquidity, and potential legal challenges during the liquidation process. The OTC Other listing further increases risk due to less regulatory oversight and greater price volatility.
What are the key factors to evaluate for AHPIQ?
Allied Healthcare Products, Inc. (AHPIQ) currently holds an AI score of 46/100, indicating low score. Key strength: Comprehensive product range in respiratory care and medical gas equipment.. Primary risk to monitor: Ongoing: Complete loss of investment due to liquidation.. This is not financial advice.
How frequently does AHPIQ data refresh on this page?
AHPIQ prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven AHPIQ's recent stock price performance?
Recent price movement in Allied Healthcare Products, Inc. (AHPIQ) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive product range in respiratory care and medical gas equipment.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider AHPIQ overvalued or undervalued right now?
Determining whether Allied Healthcare Products, Inc. (AHPIQ) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying AHPIQ?
Before investing in Allied Healthcare Products, Inc. (AHPIQ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be limited due to the company's OTC listing and Chapter 11 status.
- The analysis reflects the company's current financial condition and liquidation process.